Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-14

FDA Approved: GALANTAMINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Galantamine from Aurobindo Pharma Limited, authorizing the generic version for use in mild to moderate Alzheimer's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)

Snippet

SUPPL AP for GALANTAMINE (GALANTAMINE)